These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7705455)

  • 1. The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists.
    Schreiber R; Brocco M; Gobert A; Veiga S; Millan MJ
    Eur J Pharmacol; 1994 Dec; 271(2-3):537-41. PubMed ID: 7705455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L; Haj-Dahmane S; Hamon M
    Eur J Pharmacol; 1993 Nov; 249(1):25-35. PubMed ID: 8282017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
    Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
    J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIMT 17, a 5-HT1A receptor agonist/5-HT2A receptor antagonist, directly activates postsynaptic 5-HT inhibitory responses in the rat cerebral cortex.
    Borsini F; Ceci A; Bietti G; Donetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Sep; 352(3):283-90. PubMed ID: 8584043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
    Assié MB; Koek W
    Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
    Moser PC; Sanger DJ
    Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test.
    Estrada-Camarena E; Fernández-Guasti A; López-Rubalcava C
    Neuropsychopharmacology; 2006 Feb; 31(2):247-55. PubMed ID: 16012533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus.
    Mundey MK; Fletcher A; Marsden CA
    Neuropharmacology; 1994 Jan; 33(1):61-6. PubMed ID: 8183439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.
    De Vry J; Jentzsch KR
    Eur J Pharmacol; 1998 Sep; 357(1):1-8. PubMed ID: 9788767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential.
    Koek W; Vacher B; Cosi C; Assié MB; Patoiseau JF; Pauwels PJ; Colpaert FC
    Eur J Pharmacol; 2001 May; 420(2-3):103-12. PubMed ID: 11408031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
    Schoeffter P; Fozard JR; Stoll A; Siegl H; Seiler MP; Hoyer D
    Eur J Pharmacol; 1993 Feb; 244(3):251-7. PubMed ID: 8384569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo.
    Lejeune F; Rivet JM; Gobert A; Canton H; Millan MJ
    Eur J Pharmacol; 1993 Aug; 240(2-3):307-10. PubMed ID: 8243546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5-HT
    Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.